04:12 AM EDT, 10/03/2024 (MT Newswires) -- OncoCyte ( OCX ) said late Wednesday that it had signed a securities purchase agreement with new and existing investors, including strategic partner Bio-Rad Laboratories ( BIO/B ) , to raise about $10.2 million through a private placement.

Proceeds from the private placement, expected to close on Oct. 4, will be used for working capital and general corporate purposes.

The company said the agreement involves the sale of 3.5 million shares at $2.948 per share, with certain insiders purchasing 37,037 shares at $2.970 each.

Price: 3.2300, Change: +0.18, Percent Change: +5.90